StonvexLoading…
StonvexStonvexStonvexCore line items from BMRA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-05-31 | Annual 2024 2024-05-31 | Annual 2023 2023-05-31 | Annual 2022 2022-05-31 |
|---|---|---|---|---|
Revenue | $5.31M | $5.42M | $5.34M | $18.87M |
Operating Income | $-5.14M | $-6.37M | $-7.22M | $-4.53M |
Net Income | $-4.97M | $-5.98M | $-7.14M | $-4.53M |
EPS (Diluted) | $-2.16 | $-2.84 | $-0.50 | $-0.36 |
Total Assets | $5.95M | $9.25M | $14.45M | $11.37M |
Total Liabilities | $1.84M | $2.66M | $2.73M | $3.05M |
Cash & Equivalents | $2.40M | $4.17M | $9.72M | $5.92M |
Free Cash Flow OCF − CapEx | Not available | $-5.41M | $-5.54M | $-536.00K |
Shares Outstanding | 2.55M | 2.10M | 16.82M | 12.87M |